Table 4 Serum miRNA risk score associated with 2-year survival in patients with primary glioblastoma
From: Serum microRNA profiling in patients with glioblastoma: a survival analysis
Risk score | Event, n (%) | Event-free, n (%) | Adj. HRs (95%CI)* | P value | |
|---|---|---|---|---|---|
Overall | Low | 10 (30.3%) | 53 (72.6%) | reference | |
High | 23 (69.7%) | 20 (27.4%) | 1.92 (1.19, 10.23) | 0.008 | |
Disease-free | Low | 27 (39.7%) | 27 (73.0%) | reference | |
High | 41 (60.3%) | 10 (27.0%) | 2.03 (1.24, 4.28) | 2.35E-04 |